ERBB2 and invasive breast carcinoma: A retrospective study conducted in 96 specimens from patients with invasive breast cancer with amplification of the ERBB2 gene in the entire tissue section demonstrated there was intratumoral heterogeneity in the ERBB2 gene amplification in a subset of patients.